DRTS
Alpha Tau Medical Ltd.
NASDAQ · ILHealthcareBiotechnology
$13.47-0.59%
Price as of Jul 20, 2026
DRTS capital
Alpha Tau Medical Ltd. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.21x
- Net debt / equity
- 0.09x
- Debt / assets
- 0.13x
- Debt / EBITDA
- -0.32x
- Net debt / EBITDA
- -0.13x
Liquidity & coverage
- Current ratio
- 7.79x
- Quick ratio
- 7.79x
- Cash ratio
- 7.68x
- Interest coverage
- -3.86x
- EBITDA / interest
- -3.75x
- Working capital
- $70.9M
Cash & dividend
- FCF / debt
- -2.28x
- Cash flow / debt
- -1.86x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.